Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials

Giovanni Luca(University of Perugia), Paolo Marino(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Eliano Pio Navarese(Nicolaus Copernicus University)
European Heart Journal
October 28, 2009
Cited by 252


Related Papers